Inventor
BURKE JASON P
US16 patents
⚠️ This page may combine multiple inventors who share the name “BURKE JASON P”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV TEXAS
11 patentsUS10344025B2Jul 9, 2019
GLS1 inhibitors for treating disease
UNIV TEXAS12 citations91
US9809588B2Nov 7, 2017
GLS1 inhibitors for treating disease
UNIV TEXAS15 citations91
US11603365B2Mar 14, 2023
Salt forms and polymorphs of (r)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyridin-2-yl)acetamido) pyridazin-3-yl)-2-fluorobutyl)-n-methyl-1H-1,2,3-triazole-4-carboxamide
UNIV TEXAS4 citations85
US11370786B2Jun 28, 2022
GLS1 inhibitors for treating disease
UNIV TEXAS6 citations84
US10899740B2Jan 26, 2021
Salt forms and polymorphs of (R)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyridin-2-yl)acetamido)pyridazin-3-yl)-2-fluorobutyl)-N-methyl-1H-1,2,3-triazole-4-carboxamide
UNIV TEXAS8 citations84
US10150753B2Dec 11, 2018
Salt forms and polymorphs of (R)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyrdin-2-yl)acetamido) pyridazin-3-yl)-2-fluorobutyl)-N-methyl-1H-1,2,3-triazole-4-carboxamide
UNIV TEXAS7 citations84
US10766892B2Sep 8, 2020
GLS1 inhibitors for treating disease
UNIV TEXAS9 citations83
US10738043B2Aug 11, 2020
GLS1 inhibitors for treating disease
UNIV TEXAS6 citations83
US11958849B2Apr 16, 2024
GLS1 inhibitors for treating disease
UNIV TEXAS2 citations72
US11713313B2Aug 1, 2023
GLS1 inhibitors for treating disease
UNIV TEXAS3 citations72
US12252480B2Mar 18, 2025
Salt forms and polymorphs of (R)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyridin-2-yl)acetamido) pyridazin-3-yl)-2-fluorobutyl)-n-methyl-1H-1,2,3-triazole-4-carboxamide
UNIV TEXAS0 citations62